MB Deivės terapija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
- |
- |
0 |
0 |
0 |
0 |
2022 |
---|
40,868 |
- |
12,198 |
12,198 |
- |
0.06 |
2.05 |
74.05 |
29.85 |
12,398 |
25,411 |
32,178 |
5,631 |
2023 |
---|
43,518 |
- |
688 |
642 |
- |
0.20 |
2.42 |
81.88 |
1.48 |
13,040 |
31,502 |
23,199 |
21,343 |
Register and
explore Okredo data2023 |
---|
43,518 |
- |
688 |
642 |
- |
0.20 |
2.42 |
81.88 |
1.48 |
13,040 |
31,502 |
23,199 |
21,343 |
Register and
explore Okredo data2023
Turnover (€)
43,518 €6 % *
Sales per employee (€)
-Profit before tax (€)
688 €-94 % *
Net Profit (€)
642 €-95 % *
Profit per employee (€)
-Working capital requirement
0.20 233.33 % *
Debt-to-equity ratio
2.42 18.05 % *
Total profitability (%)
81.88 %10.57 % *
Net profitability (%)
1.48 %-95.04 % *
Equity (€)
13,040 €5 % *
Amounts Payable And Liabilities (€)
31,502 €24 % *
Non-current Assets (€)
23,199 €-28 % *
CurrentAssets (€)
21,343 €279 % *